Wang Jisheng, Lei Yi, Bao Binghao, Yu Xudong, Dai Hengheng, Chen Fei, Li Haisong, Wang Bin
Graduate School of Beijing University of Chinese Medicine.
Department of Andrology, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing.
Medicine (Baltimore). 2019 Jan;98(2):e13954. doi: 10.1097/MD.0000000000013954.
Prostate cancer is a male malignant tumor disease with high prevalence in recent years. Patients with advanced prostate cancer are more likely to have bone metastasis and strong bone pain, and even lead to pathological fracture, which has a serious impact on the quality of life of patients. Acupuncture has good clinical efficacy in treating pain caused by prostate cancer. This review hopes to adopt meta-analysis to evaluate the efficacy and safety of acupuncture in the treatment of pain caused by prostate cancer and provides evidence for its application in clinical practice.
We will search for PubMed, Cochrane Library, AMED, EMbase, WorldSciNet, Nature, Science online and China Journal Full-text Database (CNKI), China Biomedical Literature CD-ROM Database (CBM), and related randomized controlled trials included in the China Resources Database. The time is limited from the construction of the library to November 2018. We will use the criteria provided by Cochrane 5.1.0 for quality assessment and risk assessment of the included studies, and use the Revman 5.3 and Stata 13.0 software for meta-analysis of the effectiveness, recurrence rate, and symptom scores of epididymitis.
This systematic review will evaluate the efficacy and safety of acupuncture for pain caused by prostate cancer. Owing to the fact that all of the data used in this systematic review and meta-analysis have been published, this review does not require ethical approval. Furthermore, all data will be anonymously analyzed during the review process trial.
PROSPERO CRD42018111550.
前列腺癌是近年来男性中高发的恶性肿瘤疾病。晚期前列腺癌患者更容易发生骨转移并伴有强烈的骨痛,甚至导致病理性骨折,这对患者的生活质量产生严重影响。针刺在治疗前列腺癌所致疼痛方面具有良好的临床疗效。本综述希望采用荟萃分析来评估针刺治疗前列腺癌所致疼痛的疗效和安全性,并为其在临床实践中的应用提供依据。
我们将检索 PubMed、Cochrane 图书馆、AMED、EMbase、WorldSciNet、《自然》《科学》在线以及中国期刊全文数据库(CNKI)、中国生物医学文献光盘数据库(CBM),以及华润数据库中纳入的相关随机对照试验。时间范围从建库至 2018 年 11 月。我们将使用 Cochrane 5.1.0 提供的标准对纳入研究进行质量评估和风险评估,并使用 Revman 5.3 和 Stata 13.0 软件对附睾炎的有效性、复发率和症状评分进行荟萃分析。
本系统评价将评估针刺治疗前列腺癌所致疼痛的疗效和安全性。由于本系统评价和荟萃分析中使用的所有数据均已发表,因此本评价无需伦理批准。此外,在评价过程中所有数据将进行匿名分析。
PROSPERO CRD42018111550。